AGX-08

N/A

Report date: 2026/05/25 20:02:40

Base Information

Drug NameAGX-08
Drug Alias NameAGX-08rAAV2.AG-eNCRV
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector > AAV2 vector
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsGeographic Atrophy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesZhongmou Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesZhongmou Therapeutics
Inactive CompaniesN/A
Active IndicationsGeographic Atrophy
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A